{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:18:37Z","timestamp":1783523917297,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Oral mucositis (OM) is a side effect associated with cancer treatment. Hangeshashinto (HST), a Kampo medicine, was originally prescribed to treat diarrhea, gastritis, and stomatitis. Several reports have described the effects of HST for OM induced by chemotherapy in patients with gastric or colorectal cancer. In this study, the effects of HST for prevention of OM were investigated in patients undergoing hematopoietic stem cell transplantation (HSCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty patients scheduled to receive allogeneic grafts were enrolled from July 2020 to December 2021. They were randomly assigned to two groups and instructed to wash their mouth using HST dissolved in saline solution or using only saline solution three times a day. The observation period was from the initiation date of the conditioning regimen to the date of engraftment, and the end point was the incidence of OM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighteen patients developed OM, the most severe of which was Grade (G)3. There was no significant difference in the incidence of OM between the HST group and the control group. However, a negative correlation tended to be observed between the duration using HST use and the duration of OM (G2\u20133:\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.027, G3:\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.047).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study demonstrated that HST use did not clearly inhibit onset of OM but showed a tendency to inhibit OM exacerbation. However, further studies are necessary to fully understand the effects of HST on OM in patients undergoing HSCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was registered in the Japan Registry of Clinical Trials on 7 May 2020 (jRCTs071200012).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-023-08175-7","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T06:03:12Z","timestamp":1700287392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study"],"prefix":"10.1007","volume":"31","author":[{"given":"Masako","family":"Yoshimatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Kawashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Soutome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sawayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Kurogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"issue":"13","key":"8175_CR1","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1080\/14656566.2016.1217993","volume":"17","author":"A Villa","year":"2016","unstructured":"Villa A, Sonis ST (2016) Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin Pharmacother 17(13):1801\u20131807. https:\/\/doi.org\/10.1080\/14656566.2016.1217993","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"8175_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000487085","volume":"41","author":"K Berger","year":"2018","unstructured":"Berger K, Schopohl D, Bollig A, Strobach D, Rieger C, Rublee D, Ostermann H (2018) Burden of oral mucositis: a systematic review and implications for future research. Oncol Res Treat 41(6):399\u2013405. https:\/\/doi.org\/10.1159\/000487085","journal-title":"Oncol Res Treat"},{"issue":"4","key":"8175_CR3","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.21037\/tcr.2020.02.77","volume":"9","author":"AHM Al-Rudayni","year":"2020","unstructured":"Al-Rudayni AHM, Gopinath D, Maharajan MK, Menon RK, Al-Rudayni AHM, Gopinath D, Maharajan MK, Menon RK (2020) Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review. Transl Cancer Res 9(4):3126\u20133134. https:\/\/doi.org\/10.21037\/tcr.2020.02.77","journal-title":"Transl Cancer Res"},{"issue":"11","key":"8175_CR4","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q","volume":"82","author":"TJ Ruescher","year":"1998","unstructured":"Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST (1998) The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82(11):2275\u20132281","journal-title":"Cancer"},{"issue":"5","key":"8175_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S1473-3099(04)01003-5","volume":"4","author":"SF Costa","year":"2004","unstructured":"Costa SF, Miceli MH, Anaissie EJ (2004) Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? Lancet Infect Dis 4(5):278\u2013286. https:\/\/doi.org\/10.1016\/S1473-3099(04)01003-5","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"8175_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12223-017-0542-7","volume":"63","author":"J Radocha","year":"2018","unstructured":"Radocha J, Paterov\u00e1 P, Zav\u0159elov\u00e1 A, V\u00ed\u0161ek B, Gabalec F, \u017demli\u010dkov\u00e1 H, \u017d\u00e1k P (2018) Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: single center experience. Folia Microbiol (Praha) 63(2):141\u2013146. https:\/\/doi.org\/10.1007\/s12223-017-0542-7","journal-title":"Folia Microbiol (Praha)"},{"issue":"10","key":"8175_CR7","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"120","author":"RV Lalla","year":"2014","unstructured":"Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S (2014) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120(10):1453\u20131461. https:\/\/doi.org\/10.1002\/cncr.28592","journal-title":"Cancer"},{"issue":"19","key":"8175_CR8","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P (2020) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126(19):4423\u20134431. https:\/\/doi.org\/10.1002\/cncr.33100","journal-title":"Cancer"},{"issue":"1","key":"8175_CR9","first-page":"21","volume":"2","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) A biological approach to mucositis. J Support Oncol 2(1):21\u201332","journal-title":"J Support Oncol"},{"issue":"10","key":"8175_CR10","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1007\/s00520-019-04893-z","volume":"27","author":"J Bowen","year":"2019","unstructured":"Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, Bateman E, Correa ME, Raber-Durlacher J, Kandwal A, Mayo B, Nair RG, Stringer A, Ten Bohmer K, Thorpe D, Lalla RV, Sonis S, Cheng K, Elad S (2019) The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer 27(10):4023\u20134033. https:\/\/doi.org\/10.1007\/s00520-019-04893-z","journal-title":"Support Care Cancer"},{"key":"8175_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2015.00014","volume":"6","author":"S Ohnishi","year":"2015","unstructured":"Ohnishi S, Takeda H (2015) Herbal medicines for the treatment of cancer chemotherapy-induced side effects. Front Pharmacol 6:14. https:\/\/doi.org\/10.3389\/fphar.2015.00014","journal-title":"Front Pharmacol"},{"issue":"4","key":"8175_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/medicines5040130","volume":"5","author":"M Sunagawa","year":"2018","unstructured":"Sunagawa M, Yamaguchi K, Tsukada M, Ebihara N, Ikemoto H, Hisamitsu T (2018) Kampo (traditional Japanese herbal) formulae for treatment of stomatitis and oral mucositis. Medicines (Basel) 5(4):130. https:\/\/doi.org\/10.3390\/medicines5040130","journal-title":"Medicines (Basel)"},{"issue":"6","key":"8175_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4021\/wjon263w","volume":"1","author":"T Kono","year":"2010","unstructured":"Kono T, Satomi M, Chisato N, Ebisawa Y, Suno M, Asama T, Karasaki H, Matsubara K, Furukawa H (2010) Topical application of hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis. World J Oncol 1(6):232\u2013235. https:\/\/doi.org\/10.4021\/wjon263w","journal-title":"World J Oncol"},{"issue":"1","key":"8175_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-015-2767-y","volume":"76","author":"C Matsuda","year":"2015","unstructured":"Matsuda C, Munemoto Y, Mishima H, Nagata N, Oshiro M, Kataoka M, Sakamoto J, Aoyama T, Morita S, Kono T (2015) Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol 76(1):97\u2013103. https:\/\/doi.org\/10.1007\/s00280-015-2767-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"8175_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.7150\/jca.24733","volume":"9","author":"K Nishikawa","year":"2018","unstructured":"Nishikawa K, Aoyama T, Oba MS, Yoshikawa T, Matsuda C, Munemoto Y, Takiguchi N, Tanabe K, Nagata N, Imano M, Oshiro M, Fukushima R, Kataoka M, Morita S, Tsuburaya A, Mishima H, Kono T, Sakamoto J (2018) The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C). J Cancer 9(10):1725\u20131730. https:\/\/doi.org\/10.7150\/jca.24733","journal-title":"J Cancer"},{"issue":"5","key":"8175_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/bmt.2010.184","volume":"46","author":"L Vagliano","year":"2011","unstructured":"Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, Costazza G, Mega A, Matozzo V, Berni M, Alberani F, Banfi MM, Martinelli L, Munaron S, Orlando L, Lubiato L, Leanza S, Guerrato R, Rossetti A, Messina M, Barzetti L, Satta G, Dimonte V (2011) Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT\u2013results of a multicentre study. Bone Marrow Transplant 46(5):727\u2013732. https:\/\/doi.org\/10.1038\/bmt.2010.184","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"8175_CR17","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1007\/s00520-022-07073-8","volume":"30","author":"M Guberti","year":"2022","unstructured":"Guberti M, Botti S, Fusco A, Caffarri C, Cavuto S, Savoldi L, Serra N, Merli F, Piredda M, De Marinis MG (2022) Stem cell transplantation patients receiving a novel oral care protocol for oral mucositis prevention and treatment: patient-reported outcomes and quality of life. Support Care Cancer 30(7):6317\u20136325. https:\/\/doi.org\/10.1007\/s00520-022-07073-8","journal-title":"Support Care Cancer"},{"issue":"6","key":"8175_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/cancers11060857","volume":"11","author":"D Basile","year":"2019","unstructured":"Basile D, Di Nardo P, Corvaja C, Garattini SK, Pelizzari G, Lisanti C, Bortot L, Da Ros L, Bartoletti M, Borghi M, Gerratana L, Lombardi D, Puglisi F (2019) Mucosal injury during anti-cancer treatment: from pathobiology to bedside. Cancers (Basel) 11(6):857. https:\/\/doi.org\/10.3390\/cancers11060857","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8175_CR19","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.4317\/jced.51337","volume":"6","author":"B Chaveli-L\u00f3pez","year":"2014","unstructured":"Chaveli-L\u00f3pez B (2014) Oral toxicity produced by chemotherapy: a systematic review. J Clin Exp Dent 6(1):e81\u2013e90. https:\/\/doi.org\/10.4317\/jced.51337","journal-title":"J Clin Exp Dent"},{"issue":"53","key":"8175_CR20","doi-asserted-by":"publisher","first-page":"lgz011","DOI":"10.1093\/jncimonographs\/lgz011","volume":"2019","author":"RV Lalla","year":"2019","unstructured":"Lalla RV, Brennan MT, Gordon SM, Sonis ST, Rosenthal DI, Keefe DM (2019) Oral mucositis due to high-dose chemotherapy and\/or head and neck radiation therapy. J Natl Cancer Inst Monogr 2019(53):lgz011. https:\/\/doi.org\/10.1093\/jncimonographs\/lgz011","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"4","key":"8175_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbmt.2015.09.014","volume":"22","author":"HM Chaudhry","year":"2016","unstructured":"Chaudhry HM, Bruce AJ, Wolf RC, Litzow MR, Hogan WJ, Patnaik MS, Kremers WK, Phillips GL, Hashmi SK (2016) The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic review. Biol Blood Marrow Transplant 22(4):605\u2013616. https:\/\/doi.org\/10.1016\/j.bbmt.2015.09.014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"8175_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15(3):367\u2013369. https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.497","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"8175_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1182\/bloodadvances.2021004607","volume":"6","author":"I Sugiura","year":"2022","unstructured":"Sugiura I, Doki N, Hata T, Cho R, Ito T, Suehiro Y, Tanaka M, Kako S, Matsuda M, Yokoyama H, Ishikawa Y, Taniguchi Y, Hagihara M, Ozawa Y, Ueda Y, Hirano D, Sakura T, Tsuji M, Kamae T, Fujita H, Hiramoto N, Onoda M, Fujisawa S, Hatta Y, Dobashi N, Nishiwaki S, Atsuta Y, Kobayashi Y, Hayakawa F, Ohtake S, Naoe T, Miyazaki Y (2022) Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood Adv 6(2):624\u2013636. https:\/\/doi.org\/10.1182\/bloodadvances.2021004607","journal-title":"Blood Adv"},{"issue":"9","key":"8175_CR24","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9):1995\u20132025. https:\/\/doi.org\/10.1002\/cncr.20162","journal-title":"Cancer"},{"issue":"8","key":"8175_CR25","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00277-021-04568-y","volume":"100","author":"A Wysocka-S\u0142owik","year":"2021","unstructured":"Wysocka-S\u0142owik A, Gil L, \u015alebioda Z, Kr\u0119gielczak A, Dorocka-Bobkowska B (2021) Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation. Ann Hematol 100(8):2079\u20132086. https:\/\/doi.org\/10.1007\/s00277-021-04568-y","journal-title":"Ann Hematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08175-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08175-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08175-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T09:10:39Z","timestamp":1703149839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08175-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8175"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08175-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2996495\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards, and all procedures were implemented as a specified clinical trial in accordance with the Clinical Trials Act enacted in April 2018 in Japan. The study was approved by the Clinical Research Review Board of Nagasaki University on 28 April 2020 (#CRB7180001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent for participation and publication was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"707"}}